On the other hand, Zhang et al., found that TIM-3 expression either in the primary or metastatic tumor was associated with better progression-free survival (PFS) in renal cell carcinoma [48]. This evidence concerns the gene HAVCR2 and hereditary clear cell renal cell carcinoma.